Resultados al primer año de aplicada la vacuna recombinante cubana antiHVB en esquemas 012 y 016 meses

Abstract

An immunoassay analysis of the seroprotection achieved one year after vaccination with the Cuban recombinant vaccine anti-VHB, revealed immunogenicity in 100% ofthose vaccinated with the schemes 012 and 016 months and reached values 100 lU/l in 97% for both schemes. The geometrical media showed a significan reductiion with the 016 scheme but not with the 012 scheme. Consequently, we propose the use of the levels 012 scheme because of its short latency, simmety and stability of the levels anti-HBs stability antibody.